Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting

/PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early...

Related Keywords

Sydney ,New South Wales ,Australia ,Japan ,Guangzhou ,Guangdong ,China ,Hong Kong ,Singapore ,Yokohama ,Kanagawa ,Dennis Wong ,Prnewswire Arbele ,Business Development ,Chief Medical Officer ,Investor Contact ,Diana Hay ,